Monte Rosa Therapeutics
GLUE
#6973
Rank
NZ$0.77 B
Marketcap
$12.67
Share price
-5.22%
Change (1 day)
59.32%
Change (1 year)

Monte Rosa Therapeutics (GLUE) - P/B ratio

P/B ratio as of December 2024 : 2.29

According to Monte Rosa Therapeutics's latest financial reports the company has a price-to-book ratio of 31.4671.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Monte Rosa Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-312.4756.44%
2023-12-311.5816.32%
2022-12-311.36-50.34%
2021-12-312.73
2020-12-31N/A